Echinococcosis Diagnosis and Treatment Overview

Clinical Presentation

The World Health Organization (WHO) reports that cystic echinococcosis (caused by Echinococcus granulosus) affects the liver in 70% of cases, the lungs in 20%, and other organs in 10%, often with asymptomatic or life-threatening complications 1
Abdominal pain, hepatomegaly, and biliary obstruction are typical symptoms of hepatic manifestation 1
Fever and anaphylaxis can occur in case of cyst rupture 1
Cough, dyspnea, and hemoptysis are common symptoms of pulmonary manifestation 1

The WHO recommends a multidisciplinary diagnostic approach combining imaging with serological tests 1
Ultrasound is the initial imaging modality of choice for hepatic cysts 1
CT or MRI with intravenous contrast (arterial and venous phase) is used for unclear findings 1, 3
The WHO classification distinguishes different cyst stages (CE1, CE2, CE3a, CE3b, CE4, CE5) with therapeutic implications 1, 3
Daughter cysts, detached membrane ("water lily sign"), and calcification of the cyst wall are pathognomonic 3
Visible scolex as an intracystic nodule (1-2 mm in diameter) secures the diagnosis 4
Parenchymal cysts are typically round, 5-20 mm in diameter 4

The WHO recommends a multidisciplinary approach combining medical therapy with albendazole and surgical or percutaneous interventions, depending on cyst size, location, and WHO classification stage 1
Albendazole 400 mg twice daily with meals is recommended for patients ≥60 kg 1
PAIR (puncture, aspiration, injection, re-aspiration) plus medical therapy is recommended for large hepatic cysts (>5 cm) or complex cysts 1, 2
Complete surgical excision with maximum lung parenchyma preservation is the treatment of choice for lung cysts 1, 2
Radical surgical resection is necessary for E. multilocularis (alveolar echinococcosis) due to the lack of surrounding membrane 2, 5

Follow-up imaging (MRI or ultrasound) is recommended at least every 6 months until cyst resolution 1, 2
Long-term follow-up is necessary for at least a decade in cases of alveolar echinococcosis 1
Prolonged, often lifelong, albendazole courses are required for E. multilocularis, and recurrences are frequent 2